Characterization of monoclonal antibodies directed against trail or trail receptors

Cellular Immunology

Volumn 236, Issue 1-2, 2005, Pages 86-91

  Vermot Desroches, Claudine ^a   Sergent, Elise ^a   Bonnin, Brigitte ^a   Wijdenes, John ^a  

^a Diaclone   (France)

Author keywords

Apoptosis; TRAIL; TRAIL R

Indexed keywords

LIGAND; MONOCLONAL ANTIBODY; OSTEOPROTEGERIN; TRAIL R1 PROTEIN; TRAIL R2 PROTEIN; TRAIL R3 PROTEIN; TRAIL R4 PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; APOPTOSIS; CELL DEATH; CELL DIFFERENTIATION; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; TUMOR CELL;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 28844503798     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2005.08.012     Document Type: Conference Paper

References (14)

1. M.D. Jacobson, M. Weil, and M.C. Raff Programmed cell death in animal development Cell 88 1997 347 354
2. C.B. Thomson Apoptosis and the pathogenesis and treatment of disease Science 267 1995 1456 1462
3. S. Nagata Apoptosis by death factor Cell 88 1997 355 369
4. S.R. Wiley, K. Schooley, and P.J. Smolack Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 3 1995 363
5. G. Pan, K. O'Rourke, and A.M. Chinnayian The receptor for the cytotoxic ligand TRAIL Science 276 1997 111
6. G. Pan, J. Ni, Y.F. Wei, I. Yu, R. Gentz, and V.M. Dixit An antagonist decoy receptor and a death domain-containing receptor for TRAIL Science 277 1997 815
7. G.R. Screaton, J. Mongkolsapaya, X.N. Xu, A.E. Cowper, A.J. McMichael, and J.I. Bell TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL Curr. Biol. 7 1997 693
8. M.A. Degli-Espoti, P.J. Smolack, and H. Walczak Cloning and characterisation of TRAIL R3 a novel member of the emerging TRAIL receptor family J. Exp. Med. 186 1997 1165
9. J.P. Sheridan, S.A. Marsters, and R.M. Pitti Control of TRAIL-induced apoptosis by a family signalling and decoy receptors Science 277 1997 818
10. M.A. Degli-Espoti, W.C. Dougall, P.J. Smolack, J.Y. Waugh, C.A. Smith, and R.G. Coogwin The novel receptor TRAIL R4 induces NF-kB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain Immunity 7 1997 813
11. J.G. Emery, P. Mcdonnell, and M.B. Burke Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL J. Biol. Chem. 273 1998 14363 14367
12. T.S. Griffiths, and D.H. Lynch TRAIL: a molecule with multiple receptors and control mechanisms Curr. Opin. Immunol. 10 1998 559 563
13. T.S. Griffiths, S.R. Wiley, M.Z. Kubin, L.M. Sedger, C.R. Maliszewski, and N.A. Fanger Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL J. Exp. Med. 189 1999 1343 1354
14. N. Kayagaki, N. Yamaguchi, M. Nakayama, H. Eto, K. Okumura, and H. Yagita Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs J. Exp. Med. 189 1999 1451 1460